eRelevance closes seed funding of more than $1.4 million

Jan 31 2015

eRelevance Corporation (www.erelevancecorp.com), announced today that it has closed a round of seed funding of more than $1.4 million. The funding will be used to accelerate sales growth as well as continued development of advanced patient engagement technology.

A key investor in this round of funding is Martin Ventures, led by CEO, Chairman and Managing Director Charlie Martin, a health care veteran who founded hospital chain company Vanguard Health Systems which was recently acquired by Tenet Healthcare for $4.3B. Martin Ventures, with offices in Nashville, TN, Austin, TX and San Francisco, CA, invests in healthcare and technology initiatives that apply integrative approaches to simultaneously improve care, improve health and reduce the cost of health care. Martin Ventures also invests in companies that develop new technologies that allow consumers to engage in ways that are faster, more efficient and less costly. "We believe the eRelevance approach to patient engagement holds great promise," stated Mr. Martin. "We're excited to be a part of helping this young company realize its vision and make a significant impact in healthcare."

"We're extremely pleased to have Martin Ventures invest in our company, led by healthcare industry icon Charlie Martin," stated Bob Fabbio, co-founder and CEO of eRelevance Corporation. "We're doing something truly special to change the patient engagement landscape."